Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Cleary

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of Inherited Metabolic Disease|March 26, 2009
Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapyM Wood, M A Cleary, L Alderson, et al.
Genes & Development|January 1, 1993
Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitmentM A Cleary, S Stern, M Tanaka, et al.
International Journal of Paediatric Dentistry|March 3, 1998
Oral health implications in children with inborn errors of intermediary metabolism: a reviewM A Cleary, D E Francis, N M Kilpatrick
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 1, 1995
Absence of acidosis in the initial presentation of propionic acidaemiaJ H Walter, J E Wraith, M A Cleary
Molecular and Cellular Biology|May 1, 1996
The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPcV Mittal, M A Cleary, W Herr, et al.
Cancer Gene Therapy|August 29, 2009
Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical developmentD D Rao, N Senzer, M A Cleary, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Immune function in prolidase deficiencyM A Cleary, M Heaney, J M Couriel, et al.
Neuroscience|September 26, 2006
Expression of ezrin in glial tubes in the adult subventricular zone and rostral migratory streamM A Cleary, N Uboha, M R Picciotto, et al.
Journal of Inherited Metabolic Disease|January 1, 1995
Galactosaemia: relationship of IQ to biochemical control and genotypeM A Cleary, L E Heptinstall, J E Wraith, et al.
Clinical Dysmorphology|May 11, 2002
Facial appearance in glycogen storage disease type IIIM A Cleary, J H Walter, B A Kerr, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Inherited Metabolic Disease|March 26, 2009
Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapyM Wood, M A Cleary, L Alderson, et al.
Genes & Development|January 1, 1993
Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitmentM A Cleary, S Stern, M Tanaka, et al.
International Journal of Paediatric Dentistry|March 3, 1998
Oral health implications in children with inborn errors of intermediary metabolism: a reviewM A Cleary, D E Francis, N M Kilpatrick
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 1, 1995
Absence of acidosis in the initial presentation of propionic acidaemiaJ H Walter, J E Wraith, M A Cleary
Molecular and Cellular Biology|May 1, 1996
The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPcV Mittal, M A Cleary, W Herr, et al.
Cancer Gene Therapy|August 29, 2009
Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical developmentD D Rao, N Senzer, M A Cleary, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Immune function in prolidase deficiencyM A Cleary, M Heaney, J M Couriel, et al.
Neuroscience|September 26, 2006
Expression of ezrin in glial tubes in the adult subventricular zone and rostral migratory streamM A Cleary, N Uboha, M R Picciotto, et al.
Journal of Inherited Metabolic Disease|January 1, 1995
Galactosaemia: relationship of IQ to biochemical control and genotypeM A Cleary, L E Heptinstall, J E Wraith, et al.
Clinical Dysmorphology|May 11, 2002
Facial appearance in glycogen storage disease type IIIM A Cleary, J H Walter, B A Kerr, et al.
Pageof 5